How to buy Ortho Clinical Diagnostics plc Ordinary Shares stock

Ortho Clinical Diagnostics plc Ordinary Shares is a diagnostics & research business based in the US. Ortho Clinical Diagnostics plc Ordinary Shares shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics plc Ordinary Shares employs 4,500 staff and has a trailing 12-month revenue of around 0.00.

Ortho Clinical Diagnostics plc Ordinary Shares share price

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics plc Ordinary Shares shares at a glance

• Key figures

Information last updated 2021-03-24.

52-week range	$15.14 - $20.43
50-day moving average	$17.49
200-day moving average	$17.42
Wall St. target price	$24.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Ortho Clinical Diagnostics plc Ordinary Shares shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Ortho Clinical Diagnostics plc Ordinary Shares stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Ortho Clinical Diagnostics plc Ordinary Shares by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Ortho Clinical Diagnostics plc Ordinary Shares under- or over-valued?

Valuing Ortho Clinical Diagnostics plc Ordinary Shares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics plc Ordinary Shares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA

Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $390.5 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics plc Ordinary Shares's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA into context you can compare it against that of similar companies.

• Trinity Biotech (TRIB.US): USD$11.5 million
• Meridian Bioscience (VIVO.US): USD$105.8 million
• IDEXX Laboratories (IDXX.US): USD$895.7 million

Ortho Clinical Diagnostics plc Ordinary Shares financials

Revenue TTM	$1.8 billion
Operating margin TTM	6.23%
Gross profit TTM	$880.4 million
Return on assets TTM	1.97%
Return on equity TTM	0%
Profit margin	-12%
Book value	N/A
Market capitalisation	$4.5 billion

TTM: trailing 12 months

Shorting Ortho Clinical Diagnostics plc Ordinary Shares shares

There are currently 717,864 Ortho Clinical Diagnostics plc Ordinary Shares shares held short by investors – that's known as Ortho Clinical Diagnostics plc Ordinary Shares's "short interest". This figure is 24.7% up from 575,610 last month.

There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics plc Ordinary Shares shares can be evaluated.

Ortho Clinical Diagnostics plc Ordinary Shares's "short interest ratio" (SIR)

Ortho Clinical Diagnostics plc Ordinary Shares's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics plc Ordinary Shares shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics plc Ordinary Shares shares traded daily (recently around 3.4 million). Ortho Clinical Diagnostics plc Ordinary Shares's SIR currently stands at 0.21. In other words for every 100,000 Ortho Clinical Diagnostics plc Ordinary Shares shares traded daily on the market, roughly 210 shares are currently held short.

To gain some more context, you can compare Ortho Clinical Diagnostics plc Ordinary Shares's short interest ratio against those of similar companies.

• Trinity Biotech (TRIB.US): 0.2
• Meridian Bioscience (VIVO.US): 5.02
• IDEXX Laboratories (IDXX.US): 1.69

However Ortho Clinical Diagnostics plc Ordinary Shares's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics plc Ordinary Shares shares, or, against the total number of tradable Ortho Clinical Diagnostics plc Ordinary Shares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics plc Ordinary Shares's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics plc Ordinary Shares shares in existence, roughly 0 shares are currently held short) or 0.0064% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics plc Ordinary Shares shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics plc Ordinary Shares.

Find out more about how you can short Ortho Clinical Diagnostics plc Ordinary Shares stock.

Ortho Clinical Diagnostics plc Ordinary Shares share dividends

We're not expecting Ortho Clinical Diagnostics plc Ordinary Shares to pay a dividend over the next 12 months.

Ortho Clinical Diagnostics plc Ordinary Shares overview

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .

Frequently asked questions

• How many people work for Ortho Clinical Diagnostics plc Ordinary Shares?

  Latest data suggests 4,500 work at Ortho Clinical Diagnostics plc Ordinary Shares.

• When does the fiscal year end for Ortho Clinical Diagnostics plc Ordinary Shares?

  Ortho Clinical Diagnostics plc Ordinary Shares's fiscal year ends in December.

• Where is Ortho Clinical Diagnostics plc Ordinary Shares based?

  Ortho Clinical Diagnostics plc Ordinary Shares's address is: 1001 Route 202, Raritan, NJ, United States, 08869